Rigetti's Government Deals Mask Commercial Weakness, Reinforcing Wait Thesis

What happened

Zacks Investment Research reports that Rigetti Computing is seeing solid government order growth but weak commercial demand, echoing the DeepValue report's findings of a bifurcated business model with government and research buyers like DARPA and C-DAC driving near-term milestones. This dichotomy is critical because Rigetti's financials remain pre-scale, with FY25 revenue of only $7.1M and remaining performance obligations of just $3.8M, indicating limited contracted visibility beyond headline purchase orders. The company's 108-qubit system, essential for scaling, has already been delayed to around end of Q1 2026 and requires fidelity improvements from 99.0% to 99.5% for customer readiness, highlighting ongoing execution risks. Additionally, the March 2026 8-K undercut near-term conversion hopes by describing Novera orders as R&D-use systems rather than commercial deployments, suggesting weak demand from broader markets. Despite liquidity from past financings, ongoing losses and the reliance on binary milestones keep the stock a high-beta option on uncertain commercialization.

Implication

The reinforced weak commercial demand implies that near-term revenue growth may stay lumpy and dependent on less-scalable government deals, increasing volatility. This elevates the importance of monitoring the 108Q general availability and April 2026 Japan Novera delivery as near-term catalysts for sentiment. Failure to convert orders into recognized revenue could trigger further dilution risks, given the exhausted prior ATM and persistent cash burn. While successful government milestones might offer temporary boosts, sustainable valuation hinges on proving commercial traction beyond R&D placements. Therefore, investors are advised to await Q1 2026 results and RPO expansion before considering entry, aligning with the WAIT rating for risk-adjusted returns.

Thesis delta

The news article confirms the DeepValue thesis that Rigetti's growth is uneven, with government support counterbalanced by commercial struggles, requiring no major shift in the investment call. It reinforces the need for patience on commercial proof points and milestone delivery, as weak demand underscores the bear case risks. However, if government deals accelerate beyond expectations, it could marginally improve the bull scenario, but commercial conversion remains the critical bottleneck for scalable growth.